688166 Brightgene Bio-Medical Technology Co.,Ltd.
- 23.93
- +0.93+4.04%
Brightgene Bio-Medical Technology Co.,Ltd. News
Announcement of Annual Equity Distribution Implementation in 2023
An indicative announcement on the disclosure of plans to issue A-shares to specific targets in 2024
Feasibility analysis report on the use of capital raised by issuing A-shares to specific targets in 2024
Written review opinions of the board of supervisors on matters relating to the issuance of A-shares by the company to specific targets in 2024
Announcement on the issuance of A shares to specific targets in 2024, diluted immediate returns and compensation measures and commitments of related entities
Plan to issue A shares to specific targets in 2024
An empirical analysis report on the 2024 plan to issue A-shares to specific targets
Announcement on changes in the stock raising project to issue shares to specific targets using a simple procedure
Shareholder dividend return plan for the next three years (2024-2026)
Announcement on the third vesting period of the 2021 Restricted Stock Incentive Plan that did not meet the vesting conditions and the portion of the restricted shares that have not yet been vested has been granted
Jingtian Gongcheng's legal opinion on Borui Pharmaceutical's 2021 Restricted Stock Incentive Plan that did not meet the vesting conditions during the third vesting period and that the portion of the restricted shares that have not yet been vested has been granted
2023 Annual Profit Distribution Plan Announcement
Announcement on the implementation results of the share repurchase and changes in shares
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on the first repurchase of company shares through centralized bidding
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sale conditions in the share repurchase event
Repurchase Report on the Repurchase of Shares through Centralized Auction Transactions
Announcement on the use of centralized bidding transactions to repurchase shares and the company\'s implementation of the “Improve Quality, Increase Efficiency, and Value Return” action plan
Announcement on the proposed buyback and the company\'s action plan to “improve quality, increase efficiency and focus on return”
Analysis
Price Target
No Data
No Data